SlideShare une entreprise Scribd logo

Nacs wave 3 ls4

•
•
M
marc van der woerd
Santé & Médecine
1  sur  7
Télécharger pour lire hors ligne
Learning Session #4 Stories from the front line
BC AB SK MB ON QC NB NS PEI NF NY NEW APPROACH TO CONTROLLING SUPERBUGS NOUVELLE APPROCHE POUR LUTTER CONTRE LES SUPERBACT É RIES NT YT NU Welcome Teams! Bienvenue aux equipes!
Agenda ,[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object]
[object Object],[object Object]
www.stopsuperbugs.com
[object Object],[object Object]

Recommandé

My Portfolio
My PortfolioMy Portfolio
My Portfoliojorge.garciatorres
 
English 2 - Module 4 Lesson 2
English 2 - Module 4 Lesson 2English 2 - Module 4 Lesson 2
English 2 - Module 4 Lesson 2Mondstrahl
 
Writing resources
Writing resourcesWriting resources
Writing resourcesAna Elliot
 
Top tips to pass the CMA (US) Exam
Top tips to pass the CMA (US) Exam Top tips to pass the CMA (US) Exam
Top tips to pass the CMA (US) ExamRajeshwariVH
 
Rewrite systems
Rewrite systemsRewrite systems
Rewrite systemsSubramanianMuthusamy3
 
NACS Wave 3, Learning Session 3
NACS Wave 3, Learning Session 3NACS Wave 3, Learning Session 3
NACS Wave 3, Learning Session 3marc van der woerd
 
NACS Wave 3, Learning Session 3 (FR)
NACS Wave 3, Learning Session 3 (FR)NACS Wave 3, Learning Session 3 (FR)
NACS Wave 3, Learning Session 3 (FR)marc van der woerd
 
Learning Session 3 (FR)
Learning Session 3 (FR)Learning Session 3 (FR)
Learning Session 3 (FR)marc van der woerd
 

Recommandé

My Portfolio
My PortfolioMy Portfolio
My Portfoliojorge.garciatorres
 
English 2 - Module 4 Lesson 2
English 2 - Module 4 Lesson 2English 2 - Module 4 Lesson 2
English 2 - Module 4 Lesson 2Mondstrahl
 
Writing resources
Writing resourcesWriting resources
Writing resourcesAna Elliot
 
Top tips to pass the CMA (US) Exam
Top tips to pass the CMA (US) Exam Top tips to pass the CMA (US) Exam
Top tips to pass the CMA (US) ExamRajeshwariVH
 
Rewrite systems
Rewrite systemsRewrite systems
Rewrite systemsSubramanianMuthusamy3
 
NACS Wave 3, Learning Session 3
NACS Wave 3, Learning Session 3NACS Wave 3, Learning Session 3
NACS Wave 3, Learning Session 3marc van der woerd
 
NACS Wave 3, Learning Session 3 (FR)
NACS Wave 3, Learning Session 3 (FR)NACS Wave 3, Learning Session 3 (FR)
NACS Wave 3, Learning Session 3 (FR)marc van der woerd
 
Learning Session 3 (FR)
Learning Session 3 (FR)Learning Session 3 (FR)
Learning Session 3 (FR)marc van der woerd
 
Learning Session 2 (FR)
Learning Session 2 (FR)Learning Session 2 (FR)
Learning Session 2 (FR)marc van der woerd
 
Nacs wave2 ls3_fr
Nacs wave2 ls3_frNacs wave2 ls3_fr
Nacs wave2 ls3_frmarc van der woerd
 
Nacs wave 3 ls4_fr
Nacs wave 3 ls4_frNacs wave 3 ls4_fr
Nacs wave 3 ls4_frmarc van der woerd
 
Présentation agenc y v3
Présentation agenc y v3Présentation agenc y v3
Présentation agenc y v3Romain Chaumais
 
Présentation du BE - Rentrée 2010
Présentation du BE - Rentrée 2010Présentation du BE - Rentrée 2010
Présentation du BE - Rentrée 2010Bureau Etudiant Droit (ULB)
 
Learning Session 2
Learning Session 2Learning Session 2
Learning Session 2marc van der woerd
 
Acting Our Way into New Thinking
Acting Our Way into New ThinkingActing Our Way into New Thinking
Acting Our Way into New Thinkingmarc van der woerd
 
Nacs ls1 wave3_jan10
Nacs ls1 wave3_jan10Nacs ls1 wave3_jan10
Nacs ls1 wave3_jan10marc van der woerd
 
Learning Session 1
Learning Session 1Learning Session 1
Learning Session 1marc van der woerd
 
Wave 1: Learning Session 5
Wave 1: Learning Session 5Wave 1: Learning Session 5
Wave 1: Learning Session 5marc van der woerd
 
Nacs wave2 ls4_en
Nacs wave2 ls4_enNacs wave2 ls4_en
Nacs wave2 ls4_enmarc van der woerd
 
Updated shn pd presentation van
Updated shn pd presentation vanUpdated shn pd presentation van
Updated shn pd presentation vanmarc van der woerd
 
Nacs learning session2 final
Nacs learning session2 finalNacs learning session2 final
Nacs learning session2 finalmarc van der woerd
 
NACS Wave 2, LS3
NACS Wave 2, LS3NACS Wave 2, LS3
NACS Wave 2, LS3marc van der woerd
 
NACS Wave 2, Learning Session 3
NACS Wave 2, Learning Session 3NACS Wave 2, Learning Session 3
NACS Wave 2, Learning Session 3marc van der woerd
 
Trillium's PD Story 2010
Trillium's PD Story 2010 Trillium's PD Story 2010
Trillium's PD Story 2010 marc van der woerd
 
Kelowna Improv Presentation
Kelowna Improv PresentationKelowna Improv Presentation
Kelowna Improv Presentationmarc van der woerd
 
Wave 1: Learning Session 4
Wave 1: Learning Session 4Wave 1: Learning Session 4
Wave 1: Learning Session 4marc van der woerd
 
Learning Session 1 (FR)
Learning Session 1 (FR)Learning Session 1 (FR)
Learning Session 1 (FR)marc van der woerd
 
Wave 2: Learning Session 1
Wave 2: Learning Session 1Wave 2: Learning Session 1
Wave 2: Learning Session 1marc van der woerd
 
Wave 3: Learning Lesson 2 (FR)
Wave 3: Learning Lesson 2 (FR)Wave 3: Learning Lesson 2 (FR)
Wave 3: Learning Lesson 2 (FR)marc van der woerd
 
Wave 3: Learning Session 2
Wave 3: Learning Session 2Wave 3: Learning Session 2
Wave 3: Learning Session 2marc van der woerd
 

Contenu connexe

En vedette

Présentation agenc y v3
Présentation agenc y v3Présentation agenc y v3
Présentation agenc y v3Romain Chaumais
 
Acting Our Way into New Thinking
Acting Our Way into New ThinkingActing Our Way into New Thinking
Acting Our Way into New Thinkingmarc van der woerd
 
Updated shn pd presentation van
Updated shn pd presentation vanUpdated shn pd presentation van
Updated shn pd presentation vanmarc van der woerd
 
NACS Wave 2, Learning Session 3
NACS Wave 2, Learning Session 3NACS Wave 2, Learning Session 3
NACS Wave 2, Learning Session 3marc van der woerd
 

En vedette (20)

Learning Session 2 (FR)
Learning Session 2 (FR)Learning Session 2 (FR)
Learning Session 2 (FR)
 
Nacs wave2 ls3_fr
Nacs wave2 ls3_frNacs wave2 ls3_fr
Nacs wave2 ls3_fr
 
Nacs wave 3 ls4_fr
Nacs wave 3 ls4_frNacs wave 3 ls4_fr
Nacs wave 3 ls4_fr
 
Présentation agenc y v3
Présentation agenc y v3Présentation agenc y v3
Présentation agenc y v3
 
Présentation du BE - Rentrée 2010
Présentation du BE - Rentrée 2010Présentation du BE - Rentrée 2010
Présentation du BE - Rentrée 2010
 
Learning Session 2
Learning Session 2Learning Session 2
Learning Session 2
 
Acting Our Way into New Thinking
Acting Our Way into New ThinkingActing Our Way into New Thinking
Acting Our Way into New Thinking
 
Nacs ls1 wave3_jan10
Nacs ls1 wave3_jan10Nacs ls1 wave3_jan10
Nacs ls1 wave3_jan10
 
Learning Session 1
Learning Session 1Learning Session 1
Learning Session 1
 
Wave 1: Learning Session 5
Wave 1: Learning Session 5Wave 1: Learning Session 5
Wave 1: Learning Session 5
 
Nacs wave2 ls4_en
Nacs wave2 ls4_enNacs wave2 ls4_en
Nacs wave2 ls4_en
 
Updated shn pd presentation van
Updated shn pd presentation vanUpdated shn pd presentation van
Updated shn pd presentation van
 
Nacs learning session2 final
Nacs learning session2 finalNacs learning session2 final
Nacs learning session2 final
 
NACS Wave 2, LS3
NACS Wave 2, LS3NACS Wave 2, LS3
NACS Wave 2, LS3
 
NACS Wave 2, Learning Session 3
NACS Wave 2, Learning Session 3NACS Wave 2, Learning Session 3
NACS Wave 2, Learning Session 3
 
Trillium's PD Story 2010
Trillium's PD Story 2010 Trillium's PD Story 2010
Trillium's PD Story 2010
 
Kelowna Improv Presentation
Kelowna Improv PresentationKelowna Improv Presentation
Kelowna Improv Presentation
 
Wave 1: Learning Session 4
Wave 1: Learning Session 4Wave 1: Learning Session 4
Wave 1: Learning Session 4
 
Learning Session 1 (FR)
Learning Session 1 (FR)Learning Session 1 (FR)
Learning Session 1 (FR)
 
Wave 2: Learning Session 1
Wave 2: Learning Session 1Wave 2: Learning Session 1
Wave 2: Learning Session 1
 

Plus de marc van der woerd

Wave 3: Learning Lesson 2 (FR)
Wave 3: Learning Lesson 2 (FR)Wave 3: Learning Lesson 2 (FR)
Wave 3: Learning Lesson 2 (FR)marc van der woerd
 
NACS Wave 3, Learning Session 1 (FR)
NACS Wave 3, Learning Session 1 (FR)NACS Wave 3, Learning Session 1 (FR)
NACS Wave 3, Learning Session 1 (FR)marc van der woerd
 
Trillium Health Centre’s Positively Deviant Story
Trillium Health Centre’s Positively Deviant StoryTrillium Health Centre’s Positively Deviant Story
Trillium Health Centre’s Positively Deviant Storymarc van der woerd
 

Plus de marc van der woerd (14)

Wave 3: Learning Lesson 2 (FR)
Wave 3: Learning Lesson 2 (FR)Wave 3: Learning Lesson 2 (FR)
Wave 3: Learning Lesson 2 (FR)
 
Wave 3: Learning Session 2
Wave 3: Learning Session 2Wave 3: Learning Session 2
Wave 3: Learning Session 2
 
NACS Wave 3, Learning Session 1 (FR)
NACS Wave 3, Learning Session 1 (FR)NACS Wave 3, Learning Session 1 (FR)
NACS Wave 3, Learning Session 1 (FR)
 
Trillium Health Centre’s Positively Deviant Story
Trillium Health Centre’s Positively Deviant StoryTrillium Health Centre’s Positively Deviant Story
Trillium Health Centre’s Positively Deviant Story
 
Nacs wave2 ls5_en
Nacs wave2 ls5_enNacs wave2 ls5_en
Nacs wave2 ls5_en
 
Learning Session 2 (FR)
Learning Session 2 (FR)Learning Session 2 (FR)
Learning Session 2 (FR)
 
Learning Session 1 (FR)
Learning Session 1 (FR)Learning Session 1 (FR)
Learning Session 1 (FR)
 
Learning Session 4 (FR)
Learning Session 4 (FR)Learning Session 4 (FR)
Learning Session 4 (FR)
 
Learning Session 5 (FR)
Learning Session 5 (FR)Learning Session 5 (FR)
Learning Session 5 (FR)
 
Nacs ls3 wave2
Nacs ls3 wave2Nacs ls3 wave2
Nacs ls3 wave2
 
Wave 1: Learning Session 2
Wave 1: Learning Session 2Wave 1: Learning Session 2
Wave 1: Learning Session 2
 
Wave 1: Learning Session 4
Wave 1: Learning Session 4Wave 1: Learning Session 4
Wave 1: Learning Session 4
 
Wave 1: Learning Session 3
Wave 1: Learning Session 3Wave 1: Learning Session 3
Wave 1: Learning Session 3
 
Wave 1: Learning Session 1
Wave 1: Learning Session 1Wave 1: Learning Session 1
Wave 1: Learning Session 1
 

Dernier

COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxCOVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROKanhu Charan
 
low cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxlow cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxdrashraf369
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxGlomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health: the information environment.pptxThe next social challenge to public health: the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalityhardikdabas3
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseSreenivasa Reddy Thalla
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxEyobAlemu11
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMADivya Kanojiya
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfHongBiThi1
 

Dernier (20)

COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxCOVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
 
low cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxlow cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptx
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxGlomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health: the information environment.pptxThe next social challenge to public health: the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortality
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies Disease
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptx
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
 

Nacs wave 3 ls4

  • 1. Learning Session #4 Stories from the front line
  • 2. BC AB SK MB ON QC NB NS PEI NF NY NEW APPROACH TO CONTROLLING SUPERBUGS NOUVELLE APPROCHE POUR LUTTER CONTRE LES SUPERBACT É RIES NT YT NU Welcome Teams! Bienvenue aux equipes!
  • 3.
  • 4.
  • 5.
  • 7.